Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

WH and Pedi > Pedi CV > Flashcards

Pedi CV Flashcards

1
Q

4th-8th week of gestation. Major cause of death related to birth defects 0-1y. Associated with certain syndromes: Trisomy 21, DeGeorge, Apert, Cri du chat, Noonan

A

Congenital CV Disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q 
Common causes:
Infection
Autoimmune response
Environment?
Heredity
A

Acquired CV Disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Maternal: infection, substance use in pregnancy, diabetes.
Genetic: History of CHD in other family members, syndromes, other anomalies, congential or chromosomal

A

Risk factors of Pediatric Cardiovascular Disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q 
Gas exchange shifts to lungs. 
Umbilical cord cut. 
Lungs inflate (PVR decreases), SVR increases, Blood to LA increases. Flow through fetal shunts reversed: PFO closes d/t L sided pressure. PDA closes within 24-48 hours
A

Newborn (pulmonary) Circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

INCREASED PULMONARY BLOOD FLOW. ACYANOTIC. Ductus arteriosus fails to close (usually 2-3 days). Blood from aorta to PA. Common; 5-10% of infants with CHD.
Treatment: IV ibuprofen, indomethacin to stimulate closure in premature infants. Surgical ligation of PDA.
Goals: Prevent pulmonary hypertension, vascular issues

A

Patent Ductus Arteriosus (PDA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

INCREASED PULMONARY BLOOD FLOW. ACYANOTIC. L TO R SHUNT. Hole in atrial septum. Oxygenated blood from L atrium mixes with non oxygenated blood with R atrium. Common; 6-10% of CHD. May hear murmur. Echo may show dilated R ventricle.
Treatment: Rest, nutrition, surgical repair: patch placed.
Goals: Prevent adult complciations; stroke, arrythmias, pulm htn

A

Atrial Septal Defect (ASD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

INCREASED PULMONARY BLOOD FLOW. ACYANOTIC. L TO R SHUNT. Hole in ventricular septum. Oxygenated blood from L ventricle to non-oxygenated blood in R ventricle. Common; 20-25% of CHD.
Treatment: Digoxin- controls rate and rhythm. Lasix- diuresis. ACE inhibitors- decrease SVR, aortic pressure and shunting. Surgical: temporary branding of pulmonary vessels (reduce flow to lungs), patch at 3-12 mo.
Goals: Prevent heart failure and pulm htn (in moderate to large VSDs)

A

Ventricular Septal Defect (VSD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

OBSTRUCTED BLOOD FLOW. ACYANOTIC. Narrowing of the descending aorta. 5-8% of CHD. Once PDA closes, perfusion to lower extremeties impaired. 4-extremity Bps (higher in arms than legs). Treatment: Prostaglandin to keep PDA open (perfuse kidneys and lower extremities). Diuretics, O2, inotropes. Surgical repair- end to end anastomosis.
Goals: Prevent shock, heart failure, renal failure, NEC

A

Coarctation of the Aorta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

OBSTRUCTED BLOOD FLOW. ACYANOTIC. Narrowing of the aortic valve. Systemic blood flow compromised.
Treatment: Surgical repair/balloon valvuloplasty/Ross, bacterial endocarditis prophylaxis, exercise restrictions

A

Aortic Stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

OBSTRUCTED BLOOD FLOW. ACYANOTIC. L side of the heart severely underdeveloped (mitral & aortic valves ascending aorta). Decreased force of L ventricle contraction. Reduced systemic blood flow. Open PDA allows R-L shunting; mixing in R ventricle. Most common cause of death among neonates with CHD. R ventricle dilation/hypertrophy.
Treatment: Prostaglandin to keep PDA open and maintain systemic perfusion. Surgical repair- Norwood- 3 stage repair. 1) RV converted to systemic effects. 2.) Separate pulm/systemic circulation

A

Hypoplastic Left Heart Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DECREASED PULMONARY BLOOD FLOW. CYANOTIC. OBSTRUCTION OF FLOW TO LUNGS. R TO L SHUNT. Most common cyanotic heart defect in infants. Four (sometimes five) defects: Pulmonic stenosis, right ventricular hypertrophy, VSD (sometimes ASD), overriding aorta. Progressive cyanosis “tet spells” - knee to chest (decreases return to heart). 10% of CHD.
Treatment: Surgical repair- BT shunt. Close VSD/ASD. Relieve pulmonary stenosis.
Goals: Manage hypercyanotic episodes, prevent metabolic acidosis.

A

Tetralogy of Fallot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DECREASED PULMONARY BLOOD FLOW. CYANOTIC. OBSTRUCTION OF BLOOD FLOW TO LUNGS (R to L SHUNT). Flow from R ventricle to pulmonary artery obstructed. 3 types, severity can vary: subvalvular, valvular, supravalvular. 2nd most common CHD, 5-10%.
Treatment: Surgical repair: (depend on type). Valvuloplasty via cardiac cath; patch angioplasty. Lifelong prophylaxis for infective endocarditis. Goals: prevent heart failure.

A

Pulmonic Stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DECREASED PULMONARY BLOOD FLOW. OBSTRUCTION OF BLOOD FLOW TO LUNG. CYANOTIC. Pulmonic valve underdeveloped or closed. Blood cannot get to lungs for oxygenation. Cyanosis immediately. RV and tricuspid valve small, dysfunctional. ASD usually present (R-L shunting)
Treatment: Must be managed at birth- Prostaglandins immediately to keep PDA open. Goals: Manage hypercyanotic episodes. Prevent metabolic acidosis.

A

Pulmonary Atresia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DECREASED PULMONARY BLOOD FLOW. CYANOTIC. OBSTRUCTION OF BLOOD FLOW TO LUNGS. Tricuspid valve did not form- no flow from R atrium to R ventricle (CYANOSIS). ASD present (R-L shunt). R ventricle hypoplastic; R atrium enlarged/hypertrophic. L ventricle overloaded- enlarged, fx decreases. 1 in 10,000 babies. Treatment: PGA immediately to keep PDA open. 3 surgeries to establish pulmonary circulation: BT shunt, Glenn, Fontan. Prophylaxis for endocarditis. May require anticoaglant treatment.
Goals: Prevent hypoxemia

A

Tricuspid Atresia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gas exchange in the placenta. Oxygenated blood via the umbilical vein. High PVR (lungs not used yet). Placenta and PDA = low SVR. IVE to RA to Foramen Ovale to LA. SVC to RA to RV to Ductus Arteriosus to descending aorta (lungs are bypassed)

A

Fetal Circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ability to produce contraction

A

Contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Amount of blood pumped from L ventricle each minute

A

Cardiac Ouput

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How much blood pumped with each beat

A

Stroke Volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How much blood in heart/ventricle at end of diastole

A

Preload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How much pressure in great vessels

A

Afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cardiac Output formula

A

Heart Rate x Stroke Volume

22
Q 
Maintain adequate oxygenation
Maintain adequate cardiac output and tissue perfusion
Maintain adequate hydration and nutrition
Promote comfort/pain relief
Administer and manage meds
Monitor for/prevent complications
Promote growth and development
Provide support to child and family
A

Nursing Interventions for Cardiac Disorders

23
Q

Disorders with Increased Pulmonary Blood Flow, Obstructive Disorders

A

Acyanotic

24
Q

Disorders with Decreased Pulmonary Blood Flow, mixed flow disorders

A

Cyanotic

25
Q 
Asymptomatic if small defect
Tachypnea
Tachycardia
Murmur
Diaphoresis
Poor weight gain
Frequent respiratory infections
Hypotension/Heart Failure
A

S/s of acyanotic disorders

26
Q

MIXED BLOOD FLOW. CYANOTIC.
Aortia and pulmonary arteries connected to the wrong ventricles. Oxygenated blood from L ventricle back to lungs. Non-oxygenated blood from body back to R atrium. PDA, ASD, or VSD also present, allowing shunting. Common 5% of all newborns with CHD. 50% mortality rate in 1st month, 90% in 1st year if untreated.
Treatment: PGE immediately, Surgery- arterial switch procedure within 2 weeks of life
Goals: Prevent heart failure

A

Transposition of Great Arteries

27
Q

MIXED BLOOD FLOW. CYANOTIC. No division of aorta and pulmonary artery (one common great artery). VSD. Aortic and pulmonic valves fused together. Cyanosis common. Overcirculation to lungs, decreased to body. Activity/exercise limitations
Treatment: Diuretics, digoxin, Surgery- separate PA and aorta, close VSD, conduit from RV to pulm arteries.
Goals: Prevent HF and pulm htn

A

Truncus Arteriosus

28
Q

MIXED BLOOD FLOW. CYANOTIC. No connection of pulmonary veins and L atrium. Must have PFO or ASD for blood from R atrium to get to body. Cyanosis present. 1% of CHD; surgery for survival.
Treament: PGE immediately, maintain PDA. Surgery- reconnect pulmonary veins to L atrium; create ASD if not present
Goals: Prevent compression of pulmonary veins

A

Total Anomalous Pulmonary Venous Return (TAPVR)

29
Q

MIXED BLOOD FLOW. CYANOTIC. Aorta and pulmonary artery exit from R ventricle. Unoxygenated blood goes to body from R ventricle through aorta without going to lungs. Only outlet through VSD (required to survive). Often additional defects.
Treatment: Surgery- Make VSD bigger if necessary
Modified BT shunt. Arterial switch, Rastelli or Fontan. Prophylaxis for endocarditis
Goals: Prevent HF

A

Double Outlet Right Ventricle (DORV)

30
Q

Structural of functional impairment of the ventricles. Acquired.
3 categories:
Ventricular dysfunction- structural abnormalitites
Volume overload- cardiac or non cardiac
Pressure overload- obstruction
S/s vary based on age, cause, severity

A

Heart Failure

31
Q

Decreased cardiac output.
Pulmonary venous congestion: cough, tachypnea, labored breathing and diaphoresis while feeding, crackles, grunting, cyanosis
Systemic venous congestion: peripheral edema/fluid retention, ascites, enlarged liver, JVD.
Impaired CO: tachycardia, pallor, cool periphery, weak pulses, hypotension, delayed cap refill, oliguria, tiring with activity.
Increased metabolic demand: diaphoresis, poor weight gain or weight loss, FTT.

A

Heart Failure S/S

32
Q

Collaboration with multidisciplinary team
Maintain oxygenation and cardiac output
Monitor fluid balance/weight

A

Heart Failure Interventions

33
Q

Autoimmune, inflammatory. 2-4 weeks after untreated infection with Group A streptococcus (prevented with antibiotics for strep pharyngitis) Highest incidence ages 5-15y. S/s subtle or distinct: Low grade fever, joint pain (arthralgia)/ polyarthritis, red truncal rash, nodules on elbows/knees, carditis/valvulitis (murmur), chorea, CRP/ESR. Jones criteria for diagnosis. long hospitalization
Treatment: Prevent- full course of antibiotics for strep. Antibiotics, anti-inflammatory meds. Pain relief.

A

Acute Rheumatic Fever

34
Q 
Prevention of future strep
Proper use of antibiotics
S/s of heart failure
Prevention of infective endocarditis
F/U care (prevent rheumatic heart disease)
A

Teaching of Acute Rheumatic Fever

35
Q

Most cases are bacterial (staphylococci and streptococci - most common). Infection of endocardium (inner lining) and possibly valves. Vegetations grow causing dysfunction. Variety of s/s. Risk factors: CHD, CVC, intra-cardiac devices, rheumatic heart disease, IV drug use. Duke criteria for diagnosis
Treatment: Support cardiovascular system. Rest/comfort/meds (antibiotics)
Teach: Prophylactic antibiotics before dental or respiratory procedures/surgeries

A

Infective/Bacterial Endocarditis

36
Q

Disease of heart muscle. Affects size of heart chambers, wall thickness and contraction. 3 types.
Treatment: HF treatment. Frequent visit; monitor for disease progression; prevent/slow. Beta blockers. Heart transplant?

A

Cardiomyopathy

37
Q

Disease of heart muscle. Heart muscle thins, L ventricle dilated, decreased squeeze (lower CO). Caused by myocarditis (virus, chemo, Duchenne muscular dystrophy)

A

Dilated cardiomyopathy

38
Q

Disease of heart muscle. Hypertrophy of L ventricle and septum, walls become rigid. Obstruction of outflow, dysfunction of L ventricle, myocardial ischemia. Caused by genetic mutations/malformation syndromes

A

Hypertrophic cardiomyopathy

39
Q

Acute, idiopathic systemic vascular inflammatory disorder. Usually less than 5y. Exact cause unknown. 3 phases.
Treatment: Comfort, rest. Fluids, pain relief. IVIG, aspirin.

A

Kawasaki disease

40
Q

1st stage. Abrupt onset of fever, not responsive to antipyretics; widespread inflammation of small and medium sized arteries. Lasts 1-2 weeks, fever over 5 days, maculopapular rash, edema, joint pain, strawberry tongue, cracked lips, tachycardia, decreased LV function, cervical lymphadenopathy, red conjunctiva, swollen feet/hands

A

Acute stage of Kawasaki Disease

41
Q

2nd stage. Fever subsides. Desquamation of fingers/toes; high PLT count (aneurysm risk)

A

Subacute phase of Kawasaki disease

42
Q

3rd stage. Compete resolution of s/s. Usually 3 months after onset

A

Convalescent phase of Kawasaki disease

43
Q

Increase in cardiac output or peripheral vascular resistance leads to increase in BP.
Primary- no identifiable cause, most common in pediatrics
Secondary- identifiable cause (renal, renovascular, endocrine)
3 visits: Bp over 95th percentile or over 130/90
Risk factors: Overweight, male, african-american or mexican american
Treatment: Labs, lipid profile. Anti hypertensives. Low sodium, low fat diet. Weight control; developmentally appropriate activity; decrease screen time

A

Hypertension

44
Q

Prevents PDA closure

A

Prostaglandin E (PGE)

45
Q

used in conditions that require an open PDA for mixing

A

Ibuprofen/NSAIDS

46
Q

Indomethacin

A

Used to close PDA; inhibits PGE

47
Q

Alters force or strength of heart muscle contractions to increase cardiac output
Used in HF
Ex: Digoxin

A

Inotropes

48
Q

Decrease peripheral resistance, afterload & preload (can cause cough)

A

ACE inhibitors (“pril)

49
Q

Blocks beta-adrenergic receptors to decrease excitability in heart (check pulse and BP before giving)

A

beta blockers (lol)

50
Q

Medication: sodium rich diuresis (monitor u/o and K+)

A

Loop diuretics (Lasix)

51
Q

Inotropic effect, negative chronotropic effect (avoid giving with meals, monitor for toxicity

A

Cardiac glycosides (Digoxin)

WH and Pedi (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions